Logo image of OSTX

OS THERAPIES INC (OSTX) Stock Analyst Earnings Estimates

NYSEARCA:OSTX - NYSE Arca - US68764Y2072 - Common Stock - Currency: USD

2.15  -0.03 (-1.38%)

After market: 2.1101 -0.04 (-1.86%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
OSTX revenue by date.OSTX revenue by date.
N/AN/AN/A
80.60%
EBITDA
YoY % growth
OSTX ebitda by date.OSTX ebitda by date.
-4.837M-4.446M
8.09%
-4.339M
2.41%
-6.811M
-56.99%
N/AN/AN/A
EBIT
YoY % growth
OSTX ebit by date.OSTX ebit by date.
-4.837M-4.446M
8.08%
-4.343M
2.33%
-6.814M
-56.90%
N/A
345.67%
N/A
-113.67%
N/A
203.09%
Operating Margin
OSTX operating margin by date.OSTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
OSTX eps by date.OSTX eps by date.
N/AN/AN/AN/AN/A
163.44%
N/A
-105.91%
N/A
-100.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25
EPS
Q2Q % growth
-0.12-0.10
45.22%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-2.832M
-263.17%
-2.512M
-3.06%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.24 -0.08-0.16-194.12%
Q4 2024
Q2Q % growth
-0.24 -0.15-0.09-64.16%
Q3 2024
Q2Q % growth
-0.18 -0.12-0.06-47.06%
OSTX Yearly EPS VS EstimatesOSTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.5 -0.5 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
153K-153K-100.00%
OSTX Yearly Revenue VS EstimatesOSTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2026 2027 10M 20M 30M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-9.52% -56.83% 0% 0%
RevenueN/A N/A -100% -100%